Treatment of complete lobar atelectasis after infect-exacerbation of asthma with endobronchial surfactant instillation;Surfactant - Applikation bei kompletter unterlappenatelektase nach infektexazerbiertem asthma bronchiale

Pneumologie

Volumn 55, Issue 3, 2001, Pages 130-134

  Westhoff, M ^a   Freitag, L ^b  

^a St Elisabeth Hospital Gutersloh   (Germany)

^b LUNGENKLINIK HEMER   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

LUNG SURFACTANT EXTRACT;

ADULT; ARTICLE; ASTHMA; ATELECTASIS; BRONCHOSPASM; CASE REPORT; DISEASE EXACERBATION; FEMALE; HUMAN; LUNG COLLAPSE; LUNG FUNCTION; PATHOGENESIS; PRIORITY JOURNAL;

ANIMALS; ASTHMA; ATELECTASIS; BRONCHITIS; CATTLE; FEMALE; HUMANS; INFECTION; INSTILLATION, DRUG; MIDDLE AGED; PULMONARY SURFACTANTS; TOMOGRAPHY, X-RAY COMPUTED;

EID: 0035107096     PISSN: 09348387     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2001-12287     Document Type: Article

References (31)

1. Neue auffassungen über einen grundbegriff der atemmechanik. Die retraktionskraft der lunge abhängig von der oberflächenspannung in den alveolen
2. Properties, function and origin of the alveolar lining layer
3. The mucociliary system of the lung - Role of surfactants
4. Pulmonary surface tension and alveolar stability
5. Pulmonary surfactant in health and human lung diseases: State of the art
6. Surfactant und hochdosiertes ambroxol nach aspiration bei sectioeinleitung
7. Behandlung einer totalatelektase der linken lunge bei schwerem ARDS mit seitengetrennter beatmung und surfactant-applikation
8. Alveolar surfactant and adult respiratory distress syndrome. Pathogenetic role and therapeutic prospects
9. Niedrig dosierte endobronchiale surfactant applikation bei patienten mit ARDS
10. Bronchoscopic surfactant administration in patients with severe adult respiratory distress syndrome and sepsis
11. Pulmonary surfactant and chronic lung disease
12. Pulmonary surfactant, segmental atelectasis, and bronchial asthma
13. Exogenous surfactant application in respiratory failure due to chronic obstructive pulmonary disease
14. Phospholipid molecular species of bronchoalveolar lavage fluid after local allergen challenge in athma
15. Dysfunction of pulmonary surfactant in asthmatics after segmental allergen challenge
16. Antigen-induced airway inflammation in atopic subjects generates dysfunction of pulmonary surfactant
17. Exogenous surfactant therapy and mucus rheology in chronic obstructive airway diseases
18. Other uses of surfactant
19. The role of pulmonary surfactant in obstructive airways disease
20. A mechanism for masking receptors with particular application to asthma
21. A pilot study of surfactant inhalation in the treatment of asthmatic attack
22. Surfactant activity of sputum from acute asthmatic patients
23. Effects of aerosolized surfactant in patients with stable chronic bronchitis: A prospective randomized controlled trial
24. Therapeutic aerosols and airway secretions
25. Characteristics of the lipid composition of atherogenic and antiatherogenic serum lipoproteins in patients with bronchial asthma
26. Changes in the lipid composition of the blood serum lipoproteins during the hormonal treatment of patients with bronchial asthma
27. Computed tomography of lobar collapse: 2. Collapse in the absence of endobronchial obstruction
28. Types and mechanisms of pulmonary atelectasis
29. Bronchial impaction in lobar collapse: CT demonstration and pathologic correlation
30. Surfactantgabe und seitengetrennte überdruckbeatmung bei akutem lungenversagen und atelektase nach septischem abort